Back
Johnson & Johnson Vs. AbbVie, Inc. Industry Stock Comparison
Buy
62
JNJ
Johnson & Johnson
Last Price:
$202.95
Seasonality Move:
1.27%
Sell
50
ABBV
AbbVie, Inc.
Last Price:
$219.13
Seasonality Move:
2.16%
Buy
62
Johnson & Johnson (JNJ)
is a Buy
Is Johnson & Johnson a Buy, Sell or Hold?
-
The current Johnson & Johnson [JNJ] share price is $207.35. The Score for JNJ is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
JNJ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
AbbVie, Inc. (ABBV)
is a Sell
Is AbbVie, Inc. a Buy, Sell or Hold?
-
The current AbbVie, Inc. [ABBV] share price is $229.31. The Score for ABBV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $207.35The current trend is moderately bearish and JNJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABBV Stock Price Chart
What is AbbVie, Inc.'s stock price today?
-
The AbbVie, Inc. share price today is $229.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing slight buying pressure.
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.77 | Buy |
| Relative Strength Index (14 RSI): | 55.79 | Buy |
| Chaikin Money Flow: | 6206159 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.75 - 209.89) | Buy |
| Bollinger Bands (100): | (178.66 - 202.76) | Buy |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 53.89 | Buy |
| Chaikin Money Flow: | 1439571 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (224.15 - 229.33) | Buy |
| Bollinger Bands (100): | (213.73 - 231.91) | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.16 | Buy |
| 20-day SMA: | 206.99 | Buy |
| 50-day SMA: | 200.21 | Buy |
| 200-day SMA: | 174.13 | Buy |
| 8-day EMA: | 207.33 | Buy |
| 20-day EMA: | 206.45 | Buy |
| 50-day EMA: | 200.84 | Buy |
| 200-day EMA: | 180.57 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 229.37 | Sell |
| 20-day SMA: | 226.67 | Buy |
| 50-day SMA: | 226.66 | Buy |
| 200-day SMA: | 206.14 | Buy |
| 8-day EMA: | 228.82 | Buy |
| 20-day EMA: | 227.79 | Buy |
| 50-day EMA: | 226.16 | Buy |
| 200-day EMA: | 210.81 | Buy |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.87 per share.
AbbVie, Inc. Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.61 per share, and an increase next year of $1.59 per share.
Johnson & Johnson Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||